We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Study Explains Link between Genetic Variation and Vaccine Specificity and Persistence

By LabMedica International staff writers
Posted on 24 Jun 2019
Print article
Image: A micrograph of Neisseria meningitidis in cerebrospinal fluid (CSF) seen by Gram stain at 1000x magnification. Infection could be prevented by vaccination (Photo courtesy of Wikimedia Commons).
Image: A micrograph of Neisseria meningitidis in cerebrospinal fluid (CSF) seen by Gram stain at 1000x magnification. Infection could be prevented by vaccination (Photo courtesy of Wikimedia Commons).
To better explain how genetic variation affects antibody production and specificity following immunization, researchers conducted a GWAS (genome-wide association study) to examine the persistence of immunity following administration of three childhood vaccines.

The efficacy of vaccine-induced immunity depends on the considerable variability in magnitude and persistence of specific antibodies. Maintenance of these specific antibodies is essential for continuity of vaccine-induced serological protection.

Investigators at the University of Oxford (United Kingdom) conducted a genome-wide association study into the persistence of immunity to three childhood vaccines: capsular group C meningococcal (MenC), Haemophilus influenzae type b, and tetanus toxoid (TT) vaccines. Working with genetic data collected from 3,602 children in the United Kingdom and The Netherlands, the investigators analyzed approximately 6.7 million genetic variants affecting single nucleotide polymorphisms (SNPs) associated with vaccine-induced antibody levels.

Following analysis of the results, the investigators published detailed associations between variants in a locus containing a family of signal-regulatory proteins and the persistence of MenC immunity.

"Evoking robust and sustained vaccine-induced immunity from early life is a crucial component of global health initiatives to combat the burden of infectious disease," said first author Dr. Daniel O'Connor, postdoctoral researcher in pediatrics at the University of Oxford. "The mechanisms underlying the persistence of antibody are of major interest, since effectiveness and acceptability of vaccines would be improved if protection were sustained after infant immunization without the need for repeated boosting through childhood."

The vaccine study was published in the June 11, 2019, online edition of the journal Cell Reports.

Related Links:
University of Oxford

Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Gold Member
Serological Pipet Controller
PIPETBOY GENIUS
New
Biological Indicator Vials
BI-O.K.
New
Piezoelectric Micropump
Disc Pump

Print article

Channels

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more

Pathology

view channel
Image: Microscopic images showing healthy villi on the left and diseased villi on the right (Photo courtesy of Florian Jaeckle/University of Cambridge)

Powerful AI Tool Diagnoses Coeliac Disease from Biopsy Images with Over 97% Accuracy

Coeliac disease is an autoimmune disorder triggered by the consumption of gluten, causing symptoms such as stomach cramps, diarrhea, skin rashes, weight loss, fatigue, and anemia. Due to the wide variation... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.